These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 22395861)
1. URG4 upregulation is associated with tumor growth and poor survival in epithelial ovarian cancer. Li W; Zhou N Arch Gynecol Obstet; 2012 Jul; 286(1):209-15. PubMed ID: 22395861 [TBL] [Abstract][Full Text] [Related]
2. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer. Huang KJ; Sui LH Med Oncol; 2012 Mar; 29(1):318-23. PubMed ID: 21264536 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer. Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797 [TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer. Wang M; He Y; Shi L; Shi C Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma. Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788 [TBL] [Abstract][Full Text] [Related]
7. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer. Ma M; Yu N Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213 [TBL] [Abstract][Full Text] [Related]
8. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer. Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer. Yang S; Li H; Liu Y; Ning X; Meng F; Xiao M; Wang D; Lou G; Zhang Y Med Oncol; 2013 Mar; 30(1):324. PubMed ID: 23254963 [TBL] [Abstract][Full Text] [Related]
10. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423 [TBL] [Abstract][Full Text] [Related]
11. [Expressions of Ki67, PCNA and mitotic index in ovarian epithelial tumors]. Wang S; Ma XY; Xia Y; Zhang LH Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):575-80. PubMed ID: 20848772 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of ASAP1 is associated with poor prognosis in epithelial ovarian cancer. Hou T; Yang C; Tong C; Zhang H; Xiao J; Li J Int J Clin Exp Pathol; 2014; 7(1):280-7. PubMed ID: 24427349 [TBL] [Abstract][Full Text] [Related]
13. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer. Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380 [TBL] [Abstract][Full Text] [Related]
14. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. Li T; Xue H; Guo Y; Guo K Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer. Qiu JJ; Guo JJ; Lv TJ; Jin HY; Ding JX; Feng WW; Zhang Y; Hua KQ Tumour Biol; 2013 Oct; 34(5):2971-5. PubMed ID: 23712606 [TBL] [Abstract][Full Text] [Related]
16. Defective expression of Protein 4.1N is correlated to tumor progression, aggressive behaviors and chemotherapy resistance in epithelial ovarian cancer. Xi C; Ren C; Hu A; Lin J; Yao Q; Wang Y; Gao Z; An X; Liu C Gynecol Oncol; 2013 Dec; 131(3):764-71. PubMed ID: 23994105 [TBL] [Abstract][Full Text] [Related]
17. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients. Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906 [TBL] [Abstract][Full Text] [Related]
18. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC). Shuang T; Wang M; Zhou Y; Shi C Med Oncol; 2015 Dec; 32(12):260. PubMed ID: 26520143 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer. Lv Q; Sun H; Cao C; Gao B; Qi Y Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177 [TBL] [Abstract][Full Text] [Related]
20. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer. Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]